Literature DB >> 1728448

Effect of valve deformity on results and mitral regurgitation after Inoue balloon commissurotomy.

T Feldman1, J D Carroll, J M Isner, R J Chisholm, D R Holmes, A Massumi, A D Pichard, H C Herrmann, S H Stertzer, W W O'Neill.   

Abstract

BACKGROUND: The effect of valve deformity and patient age adversely affect the results of percutaneous transvenous mitral commissurotomy (PTMC) with conventional balloons. METHODS AND
RESULTS: These factors were characterized after PTMC with the Inoue balloon. The increases in mitral valve area and mitral regurgitation after the procedure were evaluated comparing echocardiographic score of 8 or less versus more than 8, age of less than 60 versus age of 60 years or more, and age of less than 70 versus age of 70 years or more. One hundred sixty-two patients (mean age, 52 +/- 14 years) were studied. For the entire group, mitral valve area increased from 1.0 to 1.8 cm2 (p less than 0.001). Valve area increased from 1.0 +/- 0.3 to 1.8 +/- 0.6 cm2 in patients with echocardiographic score of 8 or less (n = 102) and from 1.0 +/- 0.3 to 1.7 +/- 0.5 cm2 with echocardiographic score of more than 8 (n = 44). Patients less than 60 years old (n = 104) had increases in valve area from 1.0 +/- 0.3 to 1.8 +/- 0.6 cm2 versus 1.0 +/- 0.4 to 1.8 +/- 0.6 cm2 for those 60 years old or older (n = 50) (p = NS). There was no significant difference in resultant valve area when the age division was increased to less than 70 versus 70 years or more. Similarly, the percentage of patients with 2+ or greater increase in mitral regurgitation was not different for those with higher than for those with lower echocardiographic scores (4% versus 12%, p = NS), age of less than 60 versus age of 60 years or more (10% versus 10%, p = NS), or age of less than 70 versus age of 70 or more years (9% versus 18%, p = NS). Valve replacement for mitral regurgitation was performed in four patients (one emergency), all with echocardiographic scores of less than 8.
CONCLUSIONS: Age and extent of valve deformity do not have significant effects on acute results of PTMC using the Inoue balloon. Unique balloon geometry or the controlled, stepwise balloon sizing may explain these acceptable acute results in patients with more-deformed valves.

Entities:  

Mesh:

Year:  1992        PMID: 1728448     DOI: 10.1161/01.cir.85.1.180

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

1.  Mitral Regurgitation After Percutaneous Mitral Valvuloplasty: Insights Into Mechanisms and Impact on Clinical Outcomes.

Authors:  Maria Carmo P Nunes; Robert A Levine; Renato Braulio; Marcelo A Pascoal-Xavier; Sammy Elmariah; Nayana F A Gomes; Juliana R Soares; William A M Esteves; Xin Zeng; Jacob P Dal-Bianco; Livia S A Passos; Luiz G Passaglia; Victor T Ribeiro; Cláudio L Gelape; Paulo H N Costa; Lucas Lodi-Junqueira; Walderez Dutra; Timothy C Tan; Elena Aikawa; Judy Hung
Journal:  JACC Cardiovasc Imaging       Date:  2020-09-16

2.  A differentiated morphological parameter-coding system to describe the suitability of mitral valve stenoses intended for percutaneous valvotomy.

Authors:  Nikola Bogunovic; Dieter Horstkotte; Werner Scholtz; Lothar Faber; Lukas Bogunovic; Frank van Buuren
Journal:  Heart Vessels       Date:  2014-06-27       Impact factor: 2.037

3.  Predictors of developing significant mitral regurgitation following percutaneous mitral commissurotomy with inoue balloon technique.

Authors:  Abdelfatah A Elasfar; Hatem F Elsokkary
Journal:  Cardiol Res Pract       Date:  2011-08-15       Impact factor: 1.866

4.  Mitral annular calcification predicts immediate results of percutaneous transvenous mitral commissurotomy.

Authors:  Mojtaba Salarifar; Mehrnaz Rezvanfard; Hakimeh Sadeghian; Azam Safir-mardanloo; Nahid Shafii
Journal:  Cardiovasc Ultrasound       Date:  2011-10-28       Impact factor: 2.062

5.  Mitral regurgitation after percutaneous balloon mitral valvotomy in patients with rheumatic mitral stenosis: a single-center study.

Authors:  Naser Aslanabadi; Mehrnoush Toufan; Rezvaneyeh Salehi; Azin Alizadehasl; Samad Ghaffari; Bahram Sohrabi; Ahmad Separham; Ataolaah Manafi; Mohammad Bagher Mehdizadeh; Afshin Habibzadeh
Journal:  J Tehran Heart Cent       Date:  2014-07-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.